A mechanism for metabolic disease is traced to a defective cellular scaffolding that holds together the brain’s hunger cells.

Researchers have discovered that remodeling of extracellular matrix (ECM) in the hypothalamus, specifically around AgRP ...

Investigating ECM changes in the hypothalamus reveals mechanisms behind insulin resistance, offering insights into obesity ...

Today's health news includes concerns that childhood obesity guidelines could increase risk of eating disorders, bird flu ...

There has been growing interest in developing novel cannabinoid CB1 receptor inverse agonists to treat obesity and its ...

A study has shown a potential new way to treat obesity away from weight loss drugs such as Ozempic. Removing a single gene ...

Incretin therapies based on GLP-1 receptor agonism aid in the loss of weight in obesity, but a relevant part of this loss (25%-40%) is attributed to loss of lean muscle mass, which raises the risk of ...

Removing a specific gene from fat tissue could fool the body into speeding up metabolism and burning more calories, a new ...

Share on PinterestScientists have found different weight loss results in people taking tirzepatide. NurPhoto/Getty Images ...

Another contender has emerged in the race to develop oral GLP-1 drugs for weight loss. Biolexis Therapeutics’ small molecule ...